Rising temperatures are driving antibiotic resistance in salmonella across 139 countries — and brain-computer interfaces just reached 100+ clinics. Today's briefing covers two stories with serious long-term stakes.
Audio is available on Spreaker — see link below.
A study spanning eighty years, nearly half a million bacterial samples, and a hundred and thirty-nine countries has landed a clear finding: as the climate shifts, salmonella is becoming harder to treat. The numbers are in.
There's an important distinction to hold here. This research establishes a strong association between climate variables and resistance genes.
Shifting to neurotechnology, ONWARD Medical has reached what looks like a genuine commercial inflection point. The company now has its spinal cord stimulation system available in more than a hundred clinics across the United States and Europe.
The more forward-looking development is in brain-computer interfaces. ONWARD has completed two additional successful implants of its ARC-BCI system in spinal cord injury patients.
Two watchpoints from today's briefing. On the resistance side: whether policymakers move toward integrated climate and antimicrobial strategies, or treat this study as interesting and move on.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.